Skip to Content

Alogliptin use while Breastfeeding

Drugs containing Alogliptin: Nesina, Oseni, Kazano

Medically reviewed by Drugs.com. Last updated on Apr 3, 2020.

Alogliptin Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the clinical use of alogliptin during breastfeeding. An alternate drug may be preferred, especially while nursing a newborn or preterm infant. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with alogliptin.[1]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Acarbose, Glipizide, Glyburide, Insulin, Metformin, Miglitol

Substance Identification

Substance Name

Alogliptin

CAS Registry Number

850649-61-5

Drug Class

  • Breast Feeding
  • Lactation
  • Hypoglycemic Agents
  • Incretins
  • Dipeptidyl-Peptidase IV Inhibitors
  • DPP-4 Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.